EACS 2021: Reports from Aidsmap, HIV i-Base, NATAP and Medscape

The 18th European AIDS Conference (EACS 2021), organised by the European AIDS Clinical Society, was held in London, UK, and online from 27 to 30 October 2021.

Aidsmap reports:

• Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012
• Half of speciality guidelines for medical conditions suggesting HIV don’t recommend HIV testing
• First efficacy results from England’s PrEP IMPACT Trial
• New cases of multi-drug resistant HIV becoming rarer in Europe
• People living with HIV should be routinely asked about domestic abuse
• Half of trans people attending English sexual health clinics took part in PrEP IMPACT study
• Lung function declines faster in people living with HIV
• Half of Swiss mothers with HIV decide to breastfeed their baby when given the choice
• Woman with HIV with low CD4 count remained positive on SARS-CoV-2 tests for over 5 months
• Europe far from achieving hepatitis C elimination targets
• For long-term PrEP, we need better definitions of adherence, conference hears
• Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter
• Most people with HIV accept COVID-19 vaccination; more safety information would help those who are hesitant
• Levels of COVID-19 vaccination in people with HIV in central and eastern Europe vary widely
• People with HIV with CD4 counts below 200 show weaker responses to COVID-19 vaccines

HIV i-Base reports:

All reports from NATAP can be accessed here.

All reports from Medscape can be accessed here (free registration required).